Company: INMB
Filing Date: 2025-03-27
Form Type: 8-K
Source: 0001013762-25-003401
Chunk: 0

Company: Inmune Bio, Inc.
Filing Date: 2025-03-27
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02 Results
of Operations and Financial Condition.

On March 27, 2025, INmune
Bio Inc. announced its financial results for the year ended December 31, 2024 and provided a business update. The full text of the press
release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information contained
in Item 2.02 of this Current Report on Form 8-K (including Exhibit 99.1 attached hereto) shall not be deemed “filed” for purposes
of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities
of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange
Act, except as expressly provided by specific reference in such a filing.

Item 9.01 Financial statements and Exhibits